Crinetics Pharmaceuticals, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 5 Aug 2026Quarterly earnings show how the company performed recently and whether it's growing or losing money.
Public announcement of quarterly results helps investors understand company performance and future prospects.
A major deal combining two companies changes ownership and can significantly impact shareholder value and company direction.
Being acquired by another company means shareholders may receive payment and the company becomes part of a larger organization.
Shareholders vote on company leadership and major decisions, so this shows how the company is governed by its owners.
Quarterly earnings show business performance and help investors track progress over time.
Quarterly results reveal whether the company is meeting expectations and making progress toward profitability.
Stocky reads Crinetics Pharmaceuticals, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Crinetics Pharmaceuticals, Inc.'s most recent tracked filing was a 10-Q on 3 Aug 2026: Reports Q2 2026 financial results ending June 30.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.